Virginia Retirement Systems’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.53M Buy
27,000
+9,100
+51% +$403K 0.01% 615
2026
Q1
$532K Buy
17,900
+3,300
+23% +$98.6K ﹤0.01% 746
2025
Q4
$558K Buy
+14,600
New +$475K ﹤0.01% 732
2019
Q3
Sell
-23,100
Closed -$464K 1190
2019
Q2
$464K Buy
23,100
+2,600
+13% +$51.3K 0.01% 938
2019
Q1
$464K Buy
20,500
+1,800
+10% +$39.8K 0.01% 901
2018
Q4
$423K Buy
18,700
+300
+2% +$7.46K 0.01% 921
2018
Q3
$529K Sell
18,400
-11,200
-38% -$320K 0.01% 892
2018
Q2
$807K Sell
29,600
-30,700
-51% -$818K 0.01% 753
2018
Q1
$1.35M Buy
60,300
+3,900
+7% +$92.9K 0.02% 560
2017
Q4
$1.19M Sell
56,400
-31,600
-36% -$722K 0.01% 606
2017
Q3
$2.19M Buy
88,000
+14,700
+20% +$324K 0.03% 475
2017
Q2
$1.42M Sell
73,300
-1,800
-2% -$32.6K 0.02% 561
2017
Q1
$1.39M Buy
75,100
+37,400
+99% +$732K 0.02% 567
2016
Q4
$714K Sell
37,700
-1,900
-5% -$38.9K 0.01% 665
2016
Q3
$886K Buy
39,600
+1,400
+4% +$26.6K 0.01% 580
2016
Q2
$680K Buy
+38,200
New +$618K 0.01% 640
2015
Q4
$278K Buy
14,400
+400
+3% +$7.99K ﹤0.01% 873
2015
Q3
$283K Buy
+14,000
New +$415K ﹤0.01% 844

Other funds holding TVTX

Virginia Retirement Systems's TVTX Position: Q2 2026 in Review

Virginia Retirement Systems increased its Travere Therapeutics (TVTX) stake by 51% in Q2 2026, buying an estimated $403K and bringing the position to 27,000 shares worth $1.53M. The position accounts for 0.01% of the portfolio, ranked #615.

Virginia Retirement Systems first reported a position in TVTX in Q3 2015 and has held it in 18 quarters since. The position peaked at $2.19M in Q3 2017. 321 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

  • Virginia Retirement Systems held 27,000 shares of Travere Therapeutics worth $1.53M as of Q2 2026.
  • Virginia Retirement Systems bought 9,100 Travere Therapeutics shares in Q2 2026, an estimated $403K.
  • Travere Therapeutics made up 0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #615 holding.
  • Virginia Retirement Systems first reported a position in Travere Therapeutics in Q3 2015 and has held it in 18 quarters since.
  • Virginia Retirement Systems's Travere Therapeutics position peaked at $2.19M in Q3 2017.
  • 321 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.